FutureChem Co., Ltd. Logo

FutureChem Co., Ltd.

Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.

220100 | KO

Overview

Corporate Details

ISIN(s):
KR7220100002
LEI:
Country:
South Korea
Address:
서울특별시 성동구 성수일로8길 59 평화빌딩 B동 3층(성수동2가), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

FutureChem Co., Ltd. is a global radiopharmaceutical company specializing in the development, manufacturing, and distribution of radioactive medical products. The company's portfolio focuses on diagnostic agents for conditions such as various cancers, Alzheimer's, and Parkinson's disease. In addition to finished pharmaceuticals, FutureChem produces and supplies related precursors, chemical compounds, synthesis reagents, and automated synthesis modules. The company actively establishes international partnerships to expand its presence in the global nuclear medicine and molecular imaging markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-09-15 00:00
Legal Proceedings Report
[기재정정]투자판단관련주요경영사항(임상시험결과) (전립선암 치료용 [Lu177]Ludotadipep 방사성의약품 FC7…
Korean 25.0 KB
2025-09-04 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청등결정) (전이성 거세저항성 전립선암 환자에서 [177Lu]루도타다이 펩의 유…
Korean 12.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-07-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-07-10 00:00
Regulatory News Service
투자판단관련주요경영사항 (프로스타뷰([F18]플로라스타민)주사액 식품의약품안전처 신약 허가)
Korean 13.7 KB
2025-07-09 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험결과) ([F18]Florastamin 제3상 임상시험 결과보고서 수령)
Korean 12.1 KB
2025-07-09 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험결과) ([F18]Florastamin 제3상 임상시험 결과보고서 수령)
Korean 12.7 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-08 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (전립선암 치료용 [Lu177]Ludotadipep 방사성의약품 FC705 의 국…
Korean 16.2 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 22.4 KB
2025-03-14 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 523.9 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 171.6 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.3 KB
2025-03-10 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 153.4 KB

Automate Your Workflow. Get a real-time feed of all FutureChem Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for FutureChem Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for FutureChem Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ARROWHEAD PHARMACEUTICALS, INC. Logo
Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.
United States of America
ARWR
ARS Pharmaceuticals, Inc. Logo
Develops the first FDA-approved, needle-free epinephrine spray for severe allergic reactions.
United States of America
SPRY
ARTELO BIOSCIENCES, INC. Logo
Develops lipid-signaling therapeutics for cancer, pain, anxiety, and depression.
United States of America
ARTL
Artiva Biotherapeutics, Inc. Logo
Develops allogeneic, off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America
ARTV
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden
ACE
Ascendis Pharma A/S Logo
Biopharma using proprietary TransCon® tech to develop therapies for rare diseases & oncology.
United States of America
ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.
United States of America
AAPG
Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.
Japan
4886
Aspire Biopharma Holdings, Inc. Logo
Developing a nano-platform for rapid, sublingual delivery of reformulated medications.
United States of America
ASBP
ASSEMBLY BIOSCIENCES, INC. Logo
Clinical-stage biopharma developing small-molecule antivirals for herpes, HBV, and HDV.
United States of America
ASMB

Talk to a Data Expert

Have a question? We'll get back to you promptly.